146 related articles for article (PubMed ID: 34348562)
1. Nomogram prediction for the involution of the ablation zone after radiofrequency ablation treatment in patients with low-risk papillary thyroid carcinoma.
He H; Zhang Y; Song Q; Zhao J; Li W; Li Y; Luo Y
Int J Hyperthermia; 2021; 38(1):1133-1139. PubMed ID: 34348562
[TBL] [Abstract][Full Text] [Related]
2. Sonographic Evolution and Pathologic Findings of Papillary Thyroid Cancer After Radiofrequency Ablation: A Five-Year Retrospective Cohort Study.
Li X; Li Y; Yan L; Xiao J; Yang Z; Jing H; Zhang M; Luo Y
Thyroid; 2024 Jan; 34(1):54-63. PubMed ID: 37885207
[No Abstract] [Full Text] [Related]
3. [Validated Nomogram Predicting Clinical Outcome after Radiofrequency Ablation in the Treatment of Papillary Thyroid Microcarcinoma].
He HY; Luo YK; Zhang Y; Song Q; Li W; Zhao JH; Li Y
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2021 Jun; 43(3):322-327. PubMed ID: 34238406
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Outcomes and Risk Factors of Radiofrequency Ablation for T1N0M0 Papillary Thyroid Carcinoma.
Li X; Yan L; Xiao J; Li Y; Yang Z; Zhang M; Luo Y
JAMA Surg; 2024 Jan; 159(1):51-58. PubMed ID: 37878294
[TBL] [Abstract][Full Text] [Related]
5. [Effect of Calcification on the Ultrasound-Guided Radiofrequency Ablation of Papillary Thyroid Carcinoma].
Li YM; Yan L; Xiao J; Zhang MB; Luo YK
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2023 Oct; 45(5):803-808. PubMed ID: 37927021
[TBL] [Abstract][Full Text] [Related]
6. Rigorous radiofrequency ablation can completely treat low-risk small papillary thyroid carcinoma without affecting subsequent surgical management.
Li X; Li J; Qiao Z; Yan L; Xiao J; Li Y; Zhang M; Luo Y
Eur Radiol; 2023 Jun; 33(6):4189-4197. PubMed ID: 36538070
[TBL] [Abstract][Full Text] [Related]
7. Radiofrequency ablation for solitary T1N0M0 papillary thyroid carcinoma in the danger triangle area: a preliminary analysis.
Zhang DL; Chen S; Qiu Y; Yang JC; Hong Z; Li J; Wu SS
Int J Hyperthermia; 2024; 41(1):2305256. PubMed ID: 38314684
[TBL] [Abstract][Full Text] [Related]
8. Individual prediction of lateral neck metastasis risk in patients with unifocal papillary thyroid carcinoma.
Hei H; Song Y; Qin J
Eur J Surg Oncol; 2019 Jun; 45(6):1039-1045. PubMed ID: 30824213
[TBL] [Abstract][Full Text] [Related]
9. Ultrasonography-guided radiofrequency ablation vs. surgery for the treatment of solitary T1bN0M0 papillary thyroid carcinoma: A comparative study.
Xiao J; Zhang Y; Zhang M; Lan Y; Yan L; Luo Y; Tang J
Clin Endocrinol (Oxf); 2021 Apr; 94(4):684-691. PubMed ID: 33128786
[TBL] [Abstract][Full Text] [Related]
10. Ultrasound-Guided Radiofrequency Ablation Versus Surgery for Low-Risk Papillary Thyroid Microcarcinoma: Results of Over 5 Years' Follow-Up.
Zhang M; Tufano RP; Russell JO; Zhang Y; Zhang Y; Qiao Z; Luo Y
Thyroid; 2020 Mar; 30(3):408-417. PubMed ID: 31910107
[No Abstract] [Full Text] [Related]
11. [Analysis of risk factors and construction of predictive nomogram for early recurrence after radiofrequency ablation of hepatocellular carcinoma].
Han RC; Ma XH; Wang S; Yang Y; Feng B; Liang M; Zhao XM
Zhonghua Zhong Liu Za Zhi; 2021 May; 43(5):546-552. PubMed ID: 34034474
[No Abstract] [Full Text] [Related]
12. Comparison of ultrasound-guided radiofrequency ablation versus thyroid lobectomy for T1bN0M0 papillary thyroid carcinoma.
Yan L; Li X; Li Y; Xiao J; Zhang M; Luo Y
Eur Radiol; 2023 Jan; 33(1):730-740. PubMed ID: 35895122
[TBL] [Abstract][Full Text] [Related]
13. Ultrasound-Guided Radiofrequency Ablation
He H; Wu R; Zhao J; Song Q; Zhang Y; Luo Y
Front Endocrinol (Lausanne); 2021; 12():734432. PubMed ID: 34512557
[TBL] [Abstract][Full Text] [Related]
14. Prediction of ablation zone disappearance after microwave ablation for the patients with papillary thyroid microcarcinoma using nomograph.
Hu C; Liang S; Liu H; Yang J; Kang H; Guan S; Yan R; Xu E
Front Endocrinol (Lausanne); 2023; 14():1145958. PubMed ID: 37600691
[TBL] [Abstract][Full Text] [Related]
15. Clinical outcomes of radiofrequency ablation for solitary T1aN0M0 versus T1bN0M0 papillary thyroid carcinoma: a propensity-matched cohort study.
Tong M; Wang L; Gai Z; Zhu Y; Che Y
Int J Hyperthermia; 2023; 40(1):2257908. PubMed ID: 37848402
[TBL] [Abstract][Full Text] [Related]
16. [Short-term Outcome of T1bN0M0 Papillary Thyroid Cancer after Ultrasonography-guided Radiofrequency Ablation].
Xiao J; Lan Y; Yan L; Zhang MB; Zhang Y; Xie F; Song Q; Luo YK; Tang J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2020 Dec; 42(6):771-775. PubMed ID: 33423724
[TBL] [Abstract][Full Text] [Related]
17. A nomogram to predict skip metastasis in papillary thyroid cancer.
Wang W; Yang Z; Ouyang Q
World J Surg Oncol; 2020 Jul; 18(1):167. PubMed ID: 32669128
[TBL] [Abstract][Full Text] [Related]
18. Nomogram including chemotherapy response for prediction of intrahepatic progression-free survival in patients with colorectal liver metastasis through chemotherapy followed by radiofrequency ablation.
Wu H; Liu GJ; Zhang ZY; Wu W; Meng YF; Wang S; Yang W; Yan K
Int J Hyperthermia; 2021; 38(1):633-639. PubMed ID: 33882789
[TBL] [Abstract][Full Text] [Related]
19. Surgery After Ultrasound-Guided Radiofrequency Ablation for Papillary Thyroid Carcinoma in 21 Patients: A Retrospective Study from a Single Center in China.
Sun W; Zhang H; He L; Zhang T; Wang Z; Dong W; Jiang Y
Med Sci Monit; 2020 Nov; 26():e928391. PubMed ID: 33221812
[TBL] [Abstract][Full Text] [Related]
20. Longer-term outcomes of radiofrequency ablation for locally recurrent papillary thyroid cancer.
Chung SR; Baek JH; Choi YJ; Lee JH
Eur Radiol; 2019 Sep; 29(9):4897-4903. PubMed ID: 30805701
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
